Matthias Holdhoff

Associate Professor

20022019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Matthias Holdhoff is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Glioma Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Brain Neoplasms Medicine & Life Sciences
Central Nervous System Medicine & Life Sciences
Mutation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

Aquaporin-4 Expression Patterns in Glioblastoma Pre-Chemoradiation and at Time of Suspected Progression

Levy, M., Barletta, S., Huang, H., Grossman, S. A., Rodriguez, F. J., Ellsworth, S. G., Dzaye, O. & Holdhoff, M., Feb 7 2019, In : Cancer Investigation. 37, 2, p. 67-72 6 p.

Research output: Contribution to journalArticle

Aquaporin 4
Glioblastoma
Edema
Staining and Labeling
Biopsy
Image-Guided Biopsy
Validation Studies
Amides
Glioma
Protons

Immune-related adverse events requiring hospitalization: Spectrum of toxicity, treatment, and outcomes

Balaji, A., Zhang, J., Wills, B., Marrone, K., Elmariah, H., Yarchoan, M., Zimmerman, J. W., Hajjir, K., Venkatraman, D., Armstrong, D. K., Laheru, D., Mehra, R., Ho, W. J., Reuss, J. E., Heng, J., Vellanki, P., Donehower, R. C., Holdhoff, M. & Naidoo, J., Jan 1 2019, In : Journal of oncology practice. 15, 9, p. E825-E834

Research output: Contribution to journalArticle

Hospitalization
Gastroenterology
Immunotherapy
Inpatients
Referral and Consultation

Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas

Schreck, K. C., Ranjan, S., Skorupan, N., Bettegowda, C., Eberhart, C. G., Ames, H. M. & Holdhoff, M., Jan 1 2019, In : Journal of neuro-oncology.

Research output: Contribution to journalArticle

Open Access
Glioma
Mutation
Incidence
Neoplasms
Survival

MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas

Nayyar, N., White, M. D., Gill, C. M., Lastrapes, M., Bertalan, M., Kaplan, A., D'Andrea, M. R., Bihun, I., Kaneb, A., Dietrich, J., Ferry, J. A., Martinez-Lage, M., Giobbie-Hurder, A., Borger, D. R., Rodriguez, F. J., Frosch, M. P., Batchelor, E., Hoang, K., Kuter, B., Fortin, S. & 5 others, Holdhoff, M., Cahill, D. P., Carter, S., Brastianos, P. K. & Batchelor, T. T., Feb 12 2019, In : Blood advances. 3, 3, p. 375-383 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Lymphoma
Central Nervous System
Exome
Mutation